NEWS FEED:11:58 AM UnionPay and Paymob Launch Massive POS Expansion in Egypt • 11:45 AM Adam Levine and Behati Prinsloo Mark 12 Years Amid Lingering Scrutiny • 11:42 AM SM Group Secures 24 Accolades for Corporate Governance • 11:42 AM Sasol Surpasses FY26 Performance Targets Amid Global Market Volatility • 11:42 AM Acron Aviation to Supply Avionics for Deutsche Aircraft D328eco • 11:29 AM Whoopi Goldberg Moves Anne Hathaway to Tears on The View
Home › Releases › Krystal Biotech, Tutor Perini and V2X to Join S&P ...

» Sections

Releases

Krystal Biotech, Tutor Perini and V2X to Join S&P Indices

21.07.2026 00:451,1810
Krystal Biotech, Tutor Perini and V2X to Join S&P Indices

A series of corporate acquisitions is triggering a reshuffle across S&P Dow Jones Indices, as Krystal Biotech moves to the S&P MidCap 400 and Tutor Perini and V2X prepare to enter the S&P SmallCap 600. These index adjustments coincide with the pending buyouts of Taylor Morrison Home and Avanos Medical.

The transition begins on July 24, 2026, when Krystal Biotech (KRYS) shifts from the S&P SmallCap 600 to the S&P MidCap 400. This move fills the vacancy created by Taylor Morrison Home (TMHC), which is being acquired by Berkshire Hathaway. Concurrently, Tutor Perini (TPC) will step into the S&P SmallCap 600 to replace Krystal Biotech.

Following the weekend, the index updates continue on July 27 as V2X (VVX) joins the S&P SmallCap 600. The company takes the place of Avanos Medical (AVNS), which is currently being acquired by American Industrial Partners. Both index changes remain subject to the successful completion of the respective acquisition deals.

Share:TelegramXFacebook

Read Also

Comments (0)

Leave a comment

No comments yet. Be the first!